Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

2.

Molecular basis for the actions of Hsp90 inhibitors and cancer therapy.

Yamaki H, Nakajima M, Shimotohno KW, Tanaka N.

J Antibiot (Tokyo). 2011 Sep;64(9):635-44. doi: 10.1038/ja.2011.60. Epub 2011 Aug 3. Review.

PMID:
21811259
3.

Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function.

Kula A, Guerra J, Knezevich A, Kleva D, Myers MP, Marcello A.

Retrovirology. 2011 Jul 20;8:60. doi: 10.1186/1742-4690-8-60.

4.

Reciprocal regulation of human immunodeficiency virus-1 gene expression and replication by heat shock proteins 40 and 70.

Kumar M, Rawat P, Khan SZ, Dhamija N, Chaudhary P, Ravi DS, Mitra D.

J Mol Biol. 2011 Jul 29;410(5):944-58. doi: 10.1016/j.jmb.2011.04.005.

PMID:
21763498
5.

The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis.

Barnabas RV, Webb EL, Weiss HA, Wasserheit JN.

AIDS. 2011 Aug 24;25(13):1559-73. doi: 10.1097/QAD.0b013e3283491e3e. Review.

6.

Impaired infectivity of ritonavir-resistant HIV is rescued by heat shock protein 90AB1.

Joshi P, Stoddart CA.

J Biol Chem. 2011 Jul 15;286(28):24581-92. doi: 10.1074/jbc.M111.248021. Epub 2011 May 20.

7.

The search for a cure for persistent HIV reservoirs.

Lafeuillade A, Stevenson M.

AIDS Rev. 2011 Apr-Jun;13(2):63-6. Review.

PMID:
21587339
8.

Cellular heat shock factor 1 positively regulates human immunodeficiency virus-1 gene expression and replication by two distinct pathways.

Rawat P, Mitra D.

Nucleic Acids Res. 2011 Aug;39(14):5879-92. doi: 10.1093/nar/gkr198. Epub 2011 Apr 1.

9.

Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency.

Gallastegui E, Millán-Zambrano G, Terme JM, Chávez S, Jordan A.

J Virol. 2011 Apr;85(7):3187-202. doi: 10.1128/JVI.01920-10. Epub 2011 Jan 26.

10.

Primary cell models of HIV latency.

Yang HC.

Curr Opin HIV AIDS. 2011 Jan;6(1):62-7. doi: 10.1097/COH.0b013e3283412568. Review.

PMID:
21242895
11.

Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers.

Richardson PG, Mitsiades CS, Laubach JP, Lonial S, Chanan-Khan AA, Anderson KC.

Br J Haematol. 2011 Feb;152(4):367-79. doi: 10.1111/j.1365-2141.2010.08360.x. Epub 2011 Jan 10. Review.

PMID:
21219297
12.

Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors.

Allegra A, Sant'antonio E, Penna G, Alonci A, D'Angelo A, Russo S, Cannavò A, Gerace D, Musolino C.

Eur J Haematol. 2011 Feb;86(2):93-110. doi: 10.1111/j.1600-0609.2010.01558.x. Epub 2010 Dec 20. Review.

PMID:
21114539
13.

Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.

Vozzolo L, Loh B, Gane PJ, Tribak M, Zhou L, Anderson I, Nyakatura E, Jenner RG, Selwood D, Fassati A.

J Biol Chem. 2010 Dec 10;285(50):39314-28. doi: 10.1074/jbc.M110.155275. Epub 2010 Oct 11.

14.

Heat shock proteins in prostate cancer: from tumorigenesis to the clinic.

Ciocca DR, Fanelli MA, Cuello-Carrion FD, Castro GN.

Int J Hyperthermia. 2010;26(8):737-47. doi: 10.3109/02656731003776968. Epub 2010 Sep 21. Review.

PMID:
20858068
15.

Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton.

Cameron PU, Saleh S, Sallmann G, Solomon A, Wightman F, Evans VA, Boucher G, Haddad EK, Sekaly RP, Harman AN, Anderson JL, Jones KL, Mak J, Cunningham AL, Jaworowski A, Lewin SR.

Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16934-9. doi: 10.1073/pnas.1002894107. Epub 2010 Sep 13.

16.

Heat shock proteins in breast cancer progression--a suitable case for treatment?

Calderwood SK.

Int J Hyperthermia. 2010;26(7):681-5. doi: 10.3109/02656736.2010.490254. Review.

17.

Nonprogressive and progressive primate immunodeficiency lentivirus infections.

Brenchley JM, Silvestri G, Douek DC.

Immunity. 2010 Jun 25;32(6):737-42. doi: 10.1016/j.immuni.2010.06.004. Review.

18.

HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.

Trono D, Van Lint C, Rouzioux C, Verdin E, Barré-Sinoussi F, Chun TW, Chomont N.

Science. 2010 Jul 9;329(5988):174-80. doi: 10.1126/science.1191047. Review.

PMID:
20616270
19.

Effect of treating co-infections on HIV-1 viral load: a systematic review.

Modjarrad K, Vermund SH.

Lancet Infect Dis. 2010 Jul;10(7):455-63. doi: 10.1016/S1473-3099(10)70093-1. Review.

20.

Real-time imaging of the HIV-1 transcription cycle in single living cells.

Maiuri P, Knezevich A, Bertrand E, Marcello A.

Methods. 2011 Jan;53(1):62-7. doi: 10.1016/j.ymeth.2010.06.015. Epub 2010 Jun 25. Review.

PMID:
20600934

Supplemental Content

Support Center